Dr Cohen said the project holds great promise for patients at risk of colorectal cancer metastasis.
"We aim to better understand key biomarkers that may put patients in a high-risk group for developing metastatic recurrence, while also looking at when and where inside the body metastasis is most likely to occur.
“Valuable discoveries from this research can better equip clinicians to develop early intervention and individualised treatment plans to ultimately result in fewer people dying from this disease.” - Dr Ryan Cohen.
With your support, we seek to enable meaningful medical discoveries to directly improve diagnosis and treatment for colorectal cancer patients at St John of God Health Care hospitals, the broader community, and generations to come.